The largest AR repeat expansion reported in a person with SBMA is 68 (Gene Reviews, Spinal and Bulbar Muscular Atrophy); this allele is outside that range. See ClinVar:417977.
eye, with Scer\GAL4GMR.PF
eye, with Scer\GAL4GMR.PU
Expressing Hsap\ARQ112.UAS.Tag:HA under the control of Scer\GAL4GMR.PU induces loss of eye pigmentation.
Expression of Hsap\ARQ112.Scer\UAS.T:Ivir\HA1 (line P{UAS-Hsap\AR.Q112}M) under the control of Scer\GAL4GMR.PF induces mild degeneration of the external eye and more severe degeneration of the internal eye structure. Expression of Hsap\ARQ112.Scer\UAS.T:Ivir\HA1 (line P{UAS-Hsap\AR.Q112}S) under the control of Scer\GAL4GMR.PF results in a more severe degeneration of the eye.
Expression of Hsap\ARQ112.Scer\UAS.T:Ivir\HA1 in the nervous system under the control of Scer\GAL4elav-C155 confers embryonic lethality. Moderate expression of Hsap\ARQ112.Scer\UAS.T:Ivir\HA1 in the nervous system under the control of Scer\GAL4elav-C155 (using the line P{UAS-Hsap\AR.Q112}M) yields adults that display an early-death phenotype, dying within 2-5 days after eclosion with poor motility and an irregular tremor.
Moderate expression of Hsap\ARQ112.Scer\UAS.T:Ivir\HA1 in motor neurons through the Scer\GAL4D42 driver (using the line P{UAS-Hsap\AR.Q112}M) confers a less severe phenotype when compared with pan-neural expression with Scer\GAL4elav-C155, with flies starting to die 2 days after eclosion from the pupal case. All flies die with in 18 days. In addition to the early-death phenotype, these flies become less active and exhibit an irregular tremor starting at 10 days.
Hsap\ARQ112.UAS.Tag:HA, Scer\GAL4GMR.PU has visible | adult stage phenotype, enhanceable by Cul1GD9650, Scer\GAL4GMR.PU
Hsap\ARQ112.UAS.Tag:HA, Scer\GAL4GMR.PU has visible | adult stage phenotype, enhanceable by FipoQNIG.2010R, Scer\GAL4GMR.PU
Hsap\ARQ112.UAS.Tag:HA, Scer\GAL4GMR.PF, Uba2C175S.UAS has increased cell death | temperature conditional phenotype, non-suppressible by Hsap\HSPA1LUAS.cWa, Scer\GAL4GMR.PF
Hsap\ARQ112.UAS.Tag:HA, Scer\GAL4GMR.PF is an enhancer of increased cell death | temperature conditional phenotype of Scer\GAL4GMR.PF, Uba2C175S.UAS
Cul1GD9650, Hsap\ARQ112.UAS.Tag:HA, Scer\GAL4GMR.PU has increased cell death | adult stage phenotype
Hsap\ARQ112.UAS.Tag:HA, Scer\GAL4GMR.PU has eye phenotype, enhanceable by FipoQNIG.2010R, Scer\GAL4GMR.PU
Hsap\ARQ112.UAS.Tag:HA, Scer\GAL4GMR.PU has eye phenotype, enhanceable by Cul1GD9650, Scer\GAL4GMR.PU
Hsap\ARQ112.UAS.Tag:HA, Scer\GAL4GMR.PF has eye phenotype, enhanceable by Hsc70-4K71S.UAS, Scer\GAL4GMR.PF
Hsap\ARQ112.UAS.Tag:HA, Scer\GAL4GMR.PF has eye phenotype, enhanceable by Uba2C175S.UAS, Scer\GAL4GMR.PF
Hsap\ARQ112.UAS.Tag:HA, Scer\GAL4GMR.PF has eye phenotype, enhanceable by Prosβ61.UAS, Scer\GAL4GMR.PF
Hsap\ARQ112.UAS.Tag:HA, Scer\GAL4GMR.PF has eye phenotype, enhanceable by Prosβ61.UAS/Hsap\HSPA1LUAS.cWa, Scer\GAL4GMR.PF
Hsap\ARQ112.UAS.Tag:HA, Scer\GAL4GMR.PF has eye phenotype, suppressible by Hsap\HSPA1LUAS.cWa, Scer\GAL4GMR.PF
Hsap\ARQ112.UAS.Tag:HA, Scer\GAL4GMR.PF has eye phenotype, suppressible by Prosβ61.UAS/Hsap\HSPA1LUAS.cWa, Scer\GAL4GMR.PF
Hsap\ARQ112.UAS.Tag:HA, Scer\GAL4GMR.PF, Uba2C175S.UAS has eye phenotype, non-suppressible by Hsap\HSPA1LUAS.cWa, Scer\GAL4GMR.PF
Hsap\ARQ112.UAS.Tag:HA, Scer\GAL4GMR.PF, Uba2C175S.UAS has eye | temperature conditional phenotype, non-suppressible by Hsap\HSPA1LUAS.cWa, Scer\GAL4GMR.PF
Hsap\ARQ112.UAS.Tag:HA, Scer\GAL4GMR.PF, Uba2C175S.UAS has ommatidium | temperature conditional phenotype, non-suppressible by Hsap\HSPA1LUAS.cWa, Scer\GAL4GMR.PF
Hsap\ARQ112.UAS.Tag:HA, Scer\GAL4GMR.PF is an enhancer of eye | temperature conditional phenotype of Scer\GAL4GMR.PF, Uba2C175S.UAS
Hsap\ARQ112.UAS.Tag:HA, Scer\GAL4GMR.PF is an enhancer of ommatidium | temperature conditional phenotype of Scer\GAL4GMR.PF, Uba2C175S.UAS
The eye pigmentation loss induced by the expression of Hsap\ARQ112.UAS.Tag:HA under the control of Scer\GAL4GMR.PU are aggravated by the co-expression of Cul1GD9650 to the point of even leading to necrotic scars.
Co-expression of Hsap\HSPA1LScer\UAS.cWa with Hsap\ARQ112.Scer\UAS.T:Ivir\HA1 in the eye (under the control of Scer\GAL4GMR.PF suppresses the external and internal eye phenotypes associated with Hsap\ARQ112.Scer\UAS.T:Ivir\HA1.
Co-expression of Hsc70-4K71S.Scer\UAS with Hsap\ARQ112.Scer\UAS.T:Ivir\HA1 in the eye (under the control of Scer\GAL4GMR.PF enhances the eye phenotype, such that the flies show a severely degenerated eye, whereas expression of Hsap\ARQ112.Scer\UAS.T:Ivir\HA1 alone mildly affects the eye.
Co-expression of Uba2C175S.Scer\UAS with Hsap\ARQ112.Scer\UAS.T:Ivir\HA1 (both under the control of Scer\GAL4GMR.PF) results in a constant enhancement of the eye degeneration, as illustrated by severe loss of pigmentation.
Co-expression of Uba2C175S.Scer\UAS and Hsap\HSPA1LScer\UAS.cWa with Hsap\ARQ112.Scer\UAS.T:Ivir\HA1 (all under the control of Scer\GAL4GMR.PF) fails to suppress the enhancement of the eye degeneration phenotype found in Uba2C175S.Scer\UAS ; Hsap\ARQ112.Scer\UAS.T:Ivir\HA1 flies.
Co-expression of Pros261.Scer\UAS with Hsap\ARQ112.Scer\UAS.T:Ivir\HA1 (both under the control of Scer\GAL4GMR.PF) enhances the eye degeneration found with expression of Hsap\ARQ112.Scer\UAS.T:Ivir\HA1 alone. Analysis of protein extracts reveals that the enhancement of degneration is associated with a change in the solubility properties of the Hsap\ARQ112.Scer\UAS.T:Ivir\HA1 protein.
Co-expression of Pros261.Scer\UAS and Hsap\HSPA1LScer\UAS.cWa, together with the pathogenic Hsap\ARQ112.Scer\UAS.T:Ivir\HA1 lines (all under the control of the Scer\GAL4GMR.PF driver) suppress the eye phenotype.
Co-expression of Pros261.Scer\UAS and Hsc70-4K71S.Scer\UAS, together with the pathogenic Hsap\ARQ112.Scer\UAS.T:Ivir\HA1 lines (all under the control of the Scer\GAL4GMR.PF driver) enhances the eye phenotype.